Is the Options Market Predicting a Spike in Fresenius Medical Stock?

29.07.25 14:50 Uhr

Werte in diesem Artikel
Aktien

41,92 EUR -0,13 EUR -0,31%

Indizes

PKT PKT

2.066,8 PKT 19,3 PKT 0,94%

2.135,1 PKT 21,9 PKT 1,04%

24.217,4 PKT 247,0 PKT 1,03%

9.072,8 PKT 92,5 PKT 1,03%

1.902,6 PKT 0,8 PKT 0,04%

2.975,3 PKT 0,8 PKT 0,03%

2.143,9 PKT 0,6 PKT 0,03%

204,8 PKT -0,6 PKT -0,31%

570,7 PKT 4,1 PKT 0,72%

12.723,8 PKT 117,9 PKT 0,93%

24.212,0 PKT 242,0 PKT 1,01%

24.210,7 PKT 241,8 PKT 1,01%

9.371,0 PKT 88,1 PKT 0,95%

24.235,6 PKT 273,2 PKT 1,14%

Investors in Fresenius Medical Care AG FMS need to pay close attention to the stock based on moves in the options market lately. That is because the Oct 17, 2025 $12.50 Call had some of the highest implied volatility of all equity options today.What is Implied Volatility?Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.What do the Analysts Think?Clearly, options traders are pricing in a big move for Fresenius Medical shares, but what is the fundamental picture for the company? Currently, Fresenius Medical is a Zacks Rank #1 (Strong Buy) in the Medical - Instruments industry that ranks in the Bottom 31% of our Zacks Industry Rank. Over the last 60 days, no analysts have increased their earnings estimates for the current quarter, while one analyst has revised the estimate downward. The net effect has taken our Zacks Consensus Estimate for the current quarter from earnings of 51 cents per share to 50 cents in that period.Given the way analysts feel about Fresenius Medical right now, this huge implied volatility could mean there’s a trade developing. Oftentimes, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.Looking to Trade Options?Check out the simple yet high-powered approach that Zacks Executive VP Kevin Matras has used to close recent double and triple-digit winners. In addition to impressive profit potential, these trades can actually reduce your risk.Click to see the trades now >>Higher. Faster. Sooner. Buy These Stocks NowA small number of stocks are primed for a breakout, and you have a chance to get in before they take off.At any given time, there are only 220 Zacks Rank #1 Strong Buys. On average, this list more than doubles the S&P 500. We’ve combed through the latest Strong Buys and selected 7 compelling companies likely to jump sooner and climb higher than any other stock you could buy this month.You'll learn everything you need to know about these exciting trades in our brand-new Special Report, 7 Best Stocks for the Next 30 Days.Download the report free now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Fresenius Medical Care AG & Co. KGaA (FMS): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Fresenius

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Fresenius

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Fresenius SE & Co. KGaA (St.)

Wer­bung

Analysen zu Fresenius SE & Co. KGaA (St.)

DatumRatingAnalyst
22.07.2025Fresenius SECo BuyDeutsche Bank AG
22.07.2025Fresenius SECo OverweightJP Morgan Chase & Co.
22.07.2025Fresenius SECo BuyUBS AG
21.07.2025Fresenius SECo OverweightBarclays Capital
27.06.2025Fresenius SECo BuyUBS AG
DatumRatingAnalyst
22.07.2025Fresenius SECo BuyDeutsche Bank AG
22.07.2025Fresenius SECo OverweightJP Morgan Chase & Co.
22.07.2025Fresenius SECo BuyUBS AG
21.07.2025Fresenius SECo OverweightBarclays Capital
27.06.2025Fresenius SECo BuyUBS AG
DatumRatingAnalyst
13.05.2025Fresenius SECo NeutralGoldman Sachs Group Inc.
07.04.2025Fresenius SECo Market-PerformBernstein Research
26.02.2025Fresenius SECo NeutralGoldman Sachs Group Inc.
04.02.2025Fresenius SECo NeutralGoldman Sachs Group Inc.
08.11.2024Fresenius SECo NeutralGoldman Sachs Group Inc.
DatumRatingAnalyst
02.11.2021Fresenius SECo UnderperformJefferies & Company Inc.
30.07.2021Fresenius SECo UnderperformJefferies & Company Inc.
23.07.2021Fresenius SECo UnderperformJefferies & Company Inc.
17.03.2021Fresenius SECo UnderperformJefferies & Company Inc.
23.02.2021Fresenius SECo UnderperformJefferies & Company Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Fresenius SE & Co. KGaA (St.) nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen